RE: Prevalence of infectious agents in patients with systemic sclerosis: Defining the control group

Basit Öğe Kaydı
dc.contributor.authorBilgin, Hüseyin
dc.contributor.authorKocabaş, Hilal
dc.contributor.authorKeşli, Recep
dc.date.accessioned2025-10-24T18:06:52Z
dc.date.available2025-10-24T18:06:52Z
dc.date.issued2016
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.issn1303-6165
dc.identifier.issn1300-0144
dc.identifier.issue5
dc.identifier.scopus2-s2.0-84995750514
dc.identifier.scopusqualityQ1
dc.identifier.startpage1612
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3251
dc.identifier.volume46
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTurkiye Klinikleri Journal of Medical Sciences Talapapa Bulvary no. 102 Hamammonu 1 06230
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzScopus_20251023
dc.subject[No keyword]
dc.titleRE: Prevalence of infectious agents in patients with systemic sclerosis: Defining the control group
dc.typeLetter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu